(Q44342010)

2 December 2017

Determination of the amino acid residue involved in [3H]beta-funaltrexamine covalent binding in the cloned rat mu-opioid receptor (English)

1 reference

2 December 2017

0 references

Chen C

1

1 reference

2 December 2017

Yin J

2

1 reference

2 December 2017

Riel JK

3

1 reference

2 December 2017

DesJarlais RL

4

1 reference

2 December 2017

Raveglia LF

5

1 reference

2 December 2017

Zhu J

6

1 reference

2 December 2017

Liu-Chen LY

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

Journal of Biological Chemistry

2 December 2017

1 reference

2 December 2017

271

1 reference

2 December 2017

21422-21429

1 reference

2 December 2017

35

1 reference

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization

2 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Cloning of a delta opioid receptor by functional expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

mu opiate receptor: cDNA cloning and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Cloning and pharmacological characterization of a rat mu opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Affinity labels for opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Effects of beta-funaltrexamine on radiolabeled opioid binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Alkylation with beta-funaltrexamine suggests differences between mu-opioid receptor systems in guinea-pig brain and myenteric-plexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Autoradiographic study of irreversible binding of [3H]β-funaltrexamine to opioid receptors in the rat forebrain: comparison with μ and δ receptor distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Rapid and efficient site-specific mutagenesis without phenotypic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Measurement of protein using bicinchoninic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Protein assay sensitive at nanogram levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Agonists and antagonists bind to different domains of the cloned kappa opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Location of regions of the opioid receptor involved in selective agonist binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Irreversible binding of cis-(+)-3-methylfentanyl isothiocyanate to the delta opioid receptor and determination of its binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Identification and sequence of a binding site peptide of the beta 2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Importance of carbon 6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Crystal structures of alpha- and beta-funaltrexamine: conformational requirement of the fumaramate moiety in the irreversible blockage of mu opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Characterization and distribution of a cloned rat mu-opioid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Identification of cysteine-containing peptides in protein digests by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

A Film Detection Method for Tritium-Labelled Proteins and Nucleic Acids in Polyacrylamide Gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

A practical computer-based approach to the analysis of radioligand binding experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

Localization of the fourth membrane spanning domain as a ligand binding site in the human platelet alpha 2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.35.21422

21 January 2018

Identifiers

DOI

10.1074/JBC.271.35.21422

1 reference

release_2gnqhoxgbrh3bd3tn2ndedhbpa

2 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2gnqhoxgbrh3bd3tn2ndedhbpa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference